ip3r antagonist 2 apb (MedChemExpress)
Structured Review
Ip3r Antagonist 2 Apb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ip3r+antagonist/IP3+Receptor+Antibody/pm41833704-84-16-21
Average 94 stars, based on 5 article reviews
Images
Related Articles
Transfection:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Plasmid Preparation:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Expressing:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Labeling:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Imaging:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Fluorescence:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Two Tailed Test:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Blocking Assay:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Migration:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Gene Expression:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Real-time Polymerase Chain Reaction:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Quantitative RT-PCR:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Transwell Assay:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Wound Healing Assay:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Inhibition:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Transduction:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Translocation Assay:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Cell Culture:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Immunofluorescence:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Dominant Negative Mutation:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Western Blot:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Control:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Construct:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an shRNA:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Recombinant:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Sequencing:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Activity Assay:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Enzyme-linked Immunosorbent Assay:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an Software:Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z7oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from SigmaAldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTAAM (HY100545), a PKC inhibitor Midostaurin (HY10230), and an Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).TAK1 inhibitors 5Z-7-oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma-Aldrich (St. Louis, MO, USA).. An intracellular calcium chelator BAPTA-AM (HY-100545), a PKC inhibitor Midostaurin (HY-10230), and an IP3R Article Title: TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis Article Snippet: inhibitors 5Z- 7- oxozeaenol (O9890), NG25 (SML1332), and Takinib (SML2216) (#662009) were purchased from Sigma- Aldrich (St. Louis, MO, USA). .. An intracellular calcium chelator BAPTA- AM (HY- 100545), a PKC inhibitor Midostaurin (HY- 10230), and an |
![Both Ca 2+ influx and Ca 2+ release from intracellular stores contribute to the ALI-induced [Ca 2+ ] i increases. (Aa,Ab) Typical traces showing switching from normal HBSS to 0 Ca 2+ HBSS (Aa) or depletion of intracellular Ca 2+ stores with thapsigargin ( Ab , Tg, 2 μM) reduced the ALI-evoked [Ca 2+ ] i increase. Note that thapsigargin alone induced a sustained increase of [Ca 2+ ] i . (Ac,Ad) Summary data for 0 Ca 2+ HBSS ( Ac , n = 496 cells, p < 0.01); and thapsigargin ( Ad , n = 352 cells, p < 0.001). (Ba–Bc) Typical tracings showing that Xest-C (5 μM), the <t>IP3</t> <t>receptor-specific</t> antagonist (Ba) , ryanodine (100 μM), the ryanodine receptor antagonist (Bb) , and BAPTA-AM (2 μM, Bc ) reduced the ALI-induced [Ca 2+ ] i increase. (Bd–Bf) Summary data for Xest-C ( Bd , n = 224 cells, p < 0.001), ryanodine ( Be , n = 401 cells, p < 0.01), and BAPTA-AM ( Bf , n = 206 cells, p < 0.001).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6682/pmc07886682/pmc07886682__fphys-12-631022-g004.jpg)
